ORASURE TECHNOLOGIES, INC Share Repurchase Authorization
ORASURE TECHNOLOGIES, INC (OSUR) had Share Repurchase Authorization of $40.00 million as of 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Notes
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-07
- 2025-06-30: Stock Repurchase Program Authorized Amount1 $40.00M.
- 2025-03-31: Stock Repurchase Program Authorized Amount1 $40.00M.
- 2025-03-21: Stock Repurchase Program Authorized Amount1 $40.00M.
- 2008-08-05: Stock Repurchase Program Authorized Amount1 $25.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2025-06-30 | $40.00M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $40.00M 10-Q · filed 2025-05-07 |
| 2025-03-21 | $40.00M 10-Q · filed 2026-08-07 |
| 2008-08-05 | $25.00M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |